SCHEMBL1630436

SCHEMBL1630436

COc1ccc(-c2ccnn2-c2ccc(F)cc2F)c(O)c1

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ HSP90AA1 P07900 1/20 0.44
▸ MAPT P10636 3/20 0.42
▸ KDM4E B2RXH2 3/20 0.42
▸ ALDH1A1 P00352 3/20 0.42
▸ RAB9A P51151 3/20 0.42
▸ SMN1; SMN2 Q16637 2/20 0.42
▸ KDM4A O75164 1/20 0.42
▸ KDM5A P29375 1/20 0.42
▸ KDM4C Q9H3R0 1/20 0.42
▸ KDM5B Q9UGL1 1/20 0.42
▸ MAPK1 P28482 1/20 0.42
▸ LMNA P02545 1/20 0.40
▸ PIK3CD O00329 2/20 0.39
▸ NOTUM Q6P988 1/20 0.39
▸ NR3C2 P08235 1/20 0.38
▸ NPC1 O15118 3/20 0.37
▸ AMY1A P0DUB6 1/20 0.37
▸ HPGD P15428 1/20 0.36
▸ GAA P10253 1/20 0.36
▸ IDH1 O75874 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1630519 0.86 HSP90AA1 (0.60) HSP90AA1MAPTKDM4ERAB9ASMN1; SMN2
SCHEMBL1629141 0.86 HSP90AA1 (0.49) HSP90AA1RAB9AKDM4AKDM5AKDM4C
SCHEMBL1631424 0.81 MAPT (0.55) MAPTKDM4EALDH1A1RAB9AKDM4A
SCHEMBL1630200 0.81 ALDH1A1 (0.47) MAPTKDM4EALDH1A1SMN1; SMN2MAPK1
SCHEMBL1630216 0.80 HSP90AA1 (0.43) HSP90AA1MAPTKDM4EALDH1A1RAB9A
SCHEMBL1630146 0.79 ALDH1A1 (0.53) MAPTKDM4EALDH1A1RAB9ASMN1; SMN2
SCHEMBL1629669 0.78 MAPT (0.60) MAPTKDM4EALDH1A1LMNANOTUM
SCHEMBL1631440 0.78 HSP90AA1 (0.49) HSP90AA1KDM4AKDM5AKDM4CKDM5B
SCHEMBL1630437 0.77 HSP90AA1 (0.67) HSP90AA1KDM4ESMN1; SMN2KDM4AKDM5A
SCHEMBL1627411 0.77 NPC1 (0.44) HSP90AA1MAPTKDM4EALDH1A1RAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1776346-B1 1,5-Diphenylpyrazoles MERCK PATENT GMBH (DE) 2013-06-26 — — EP claimed
US-20080085904-A1 1,5-Diphenylpyrazoles MERCK PATENT GMBH (DE) 2008-04-10 — — US claimed
EP-1776346-B1 1,5-Diphenylpyrazoles MERCK PATENT GMBH (DE) 2013-06-26 — — EP disclosed
US-7932401-B2 Heat Shock Protein 90 (HSP90) inhibitors; 5-(2-hydroxy-4-methoxyphenyl)-1-(3-nitrophenyl)-1H-pyrazole for example; antitumor agent, viral diseases, transplant rejection, cystic fibrosis, angiogenesis inhibition, infectious, autoimmune, or inflammatory diseases, ischemia, chemotherapy cytoprotectant MERCK PATENT GMBH (DE) 2011-04-26 — — US disclosed
US-20080085904-A1 1,5-Diphenylpyrazoles MERCK PATENT GMBH (DE) 2008-04-10 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080085904-A1 1,5-Diphenylpyrazoles HSP90AB1, HSP90AA1, HSP90AB2P HSP90AA1 2/4885MAPT 2299/4885KDM4E 3577/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback